Cannabidiol: a promising drug for neurodegenerative disorders? - Wikidata - awgldk - TriplyDB

Cannabidiol: a promising drug for neurodegenerative disorders?

Cannabidiol: a promising drug for neurodegenerative disorders?

http://www.wikidata.org/entity/Q34948216

about

Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.Is the cardiovascular system a therapeutic target for cannabidiol?Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Generic legislation of new psychoactive drugs.Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey Medical use of cannabis. Cannabidiol: a new light for schizophrenia?Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.Cannabidiol in humans-the quest for therapeutic targets Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol.Neuroimmune pharmacology from a neuroscience perspective.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases.Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.Cannabinoids, multiple sclerosis and neuroprotection.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Cannabidiol in inflammatory bowel diseases: a brief overview.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.The Use of Cannabinoids in Treating Dementia.Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial.

P2860

Q21261356-64B3F11F-0E1D-4990-9766-8D54D94E986D Q26742059-4C5E5321-703F-4AB3-B9D5-B567874F9BDB Q26865370-F51D7BB6-F05A-4B68-84BB-7DF9EDBA8416 Q28394506-5C40129A-E5CB-466B-8D45-A4A2BCD96E90 Q28478272-7C635BE1-6FD5-431C-BB04-466D155D3829 Q30493082-0ADFD129-D856-46BA-9780-644D529EF994 Q30670447-36D3A898-F931-4DCC-A101-C8A6499FCD73 Q34035251-2DFA395F-F5C4-4968-BEF4-75E1E96446A9 Q34077887-508C9731-C127-4D23-B466-4DF096180FFE Q34308885-CB5BBA14-FED9-463F-8C21-C5EF6DF8D5A5 Q34625932-15420E24-9A00-4E19-A733-1EAF85541D4C Q34657897-D006D6EA-32CE-4F1A-96DC-D9061E2DC5EC Q34898890-1371D1E0-791F-4852-A21B-153AAF752315 Q35065638-BEF51503-4DAD-4019-A9DD-A6CE31000A6C Q35966006-D9C7DE5F-618A-45B7-93D4-BDE09FF2A56A Q36155898-9869ABDB-C041-48D4-A797-D9111C89A337 Q36719661-0AA6C059-7136-470B-8CC2-F38CA3A03913 Q36785192-24F65897-A87B-4237-881B-5B19CF35769E Q37054169-5AC8A66C-6F00-4F94-999D-3CAEE0E4310C Q37244823-3B93B008-99D4-4CD9-9EEC-EF1C22365556 Q37512670-086E0085-0C47-42DF-B0E7-9E2FFA9E6F58 Q37578039-A7DFF7DE-17B5-4F00-B5D7-1BBF8E3C57DE Q37662551-AA0474A8-692A-46BF-8A85-11CF4D7EC984 Q37780704-DCF1F181-068F-4BDE-B00C-6D95E20F236D Q37793366-131F390E-FB4C-44B5-A114-F6B84E3BA4D8 Q37798463-E47E815D-299B-4F18-A693-F80A27D7885F Q37842745-FD0EE43E-C06B-4F8C-ABAA-7E2F4C039D2B Q37960199-CE3CAC85-81E1-421F-8E56-E31D1E3DAD9E Q37997020-52BEB060-337C-4CA7-9F38-E7DA376E2794 Q38012845-D900A666-9DD4-4BC4-91E6-4C473B60F9F6 Q38027809-B2423402-1F28-4345-9253-F14160AA7319 Q38563981-C61E142E-CE4B-46EF-B1D2-F5A0C55D7EC9 Q38684679-CBE3D226-8545-48EB-8530-0508D97569FF Q38785676-2C43CA21-8CAA-4C1A-843F-37704EC59155 Q39385097-65E3F994-A882-40A4-A270-A3A014499138 Q42689224-B2F2AD6B-CC6F-423F-ACF8-8E37DC71A361 Q44205288-7DFA279A-65DD-4D67-ACF8-4FB0434DAC0F Q46293996-52F5CEED-FCC0-447A-9E28-D9601E94BE93 Q47794929-7D263707-208A-4E1E-8530-694DD34DB1B0 Q48065074-087A5DBA-5D50-4E67-845B-4E0501FCB1B8

P2860

Cannabidiol: a promising drug for neurodegenerative disorders?

http://www.wikidata.org/entity/Q34948216

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cannabidiol: a promising drug for neurodegenerative disorders?

@ast

Cannabidiol: a promising drug for neurodegenerative disorders?

@en

Cannabidiol: a promising drug for neurodegenerative disorders?

@nl

type

label

Cannabidiol: a promising drug for neurodegenerative disorders?

@ast

Cannabidiol: a promising drug for neurodegenerative disorders?

@en

Cannabidiol: a promising drug for neurodegenerative disorders?

@nl

prefLabel

Cannabidiol: a promising drug for neurodegenerative disorders?

@ast

Cannabidiol: a promising drug for neurodegenerative disorders?

@en

Cannabidiol: a promising drug for neurodegenerative disorders?

@nl

P1433

Q34948216-6EF55BE2-0927-43A9-B78E-C1B158474E4E

P1476

Q34948216-3CD77C4E-6235-4856-BA61-21B2A6FE67E9

P2093

Q34948216-EE686992-F3A6-495C-BA80-F8BD8EF7DCC4

Q34948216-FEA1D4CF-9F39-4F55-B157-77F7EF7686BD

P2860

Q34948216-20ADEE5A-FEC8-489A-A80F-323EFF684402

Q34948216-502A516E-E425-4759-A72E-E5A5D6732A3E

Q34948216-6B27AFC5-5C09-476D-B54B-547004618289

P304

Q34948216-B8CBBAD9-9B50-4741-A5C3-3BA32F64A265

P31

Q34948216-B7A250F0-8262-4F41-91FA-462B7F7F674C

P356

Q34948216-342BA3C6-36A9-4085-A424-0071B963AF55

P433

Q34948216-19E1037B-76D7-4F0D-A60A-01E7F5C0B0A9

P478

Q34948216-2A50A3FA-9F44-4522-AC87-5643F832B094

P50

Q34948216-0AF33D3E-B212-4AB7-9520-B34536428F7F

Q34948216-35D7D6AC-E1EC-4F54-8B6C-2259F5B95DE4

Q34948216-EB88C9D7-9983-4B79-8D62-76E541454B96

P577

Q34948216-2A2CC114-7EB3-4EEC-BB22-7B67DD47BFC8

P5875

Q34948216-0C262656-F237-4BF8-9BE7-ACBAC72CBC91

P698

Q34948216-E782AEE3-AE7A-4BD5-801D-37EBEEDF437F

P921

Q34948216-76330B71-E3BB-4497-B9D7-C79F5965CE55

Q34948216-9cfaca3e-4cb9-3baa-1aee-ce89e79a7de8

P932

Q34948216-6CF8C98A-E99C-4C4F-B7D1-1099A2EB58A2

P356

J.1755-5949.2008.00065.X

P1433

CNS Neuroscience & Therapeutics

P1476

Cannabidiol: a promising drug for neurodegenerative disorders?

@en

P2093

Daniele De Filippis

http://www.w3.org/2001/XMLSchema#string

Teresa Iuvone

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.

Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite

P304

65-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5949.2008.00065.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Esposito

Caterina Scuderi

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24026087

http://www.w3.org/2001/XMLSchema#string

P698

19228180

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

6494021

http://www.w3.org/2001/XMLSchema#string